Automated And Closed Cell Therapy Processing Systems Market Demand Forecast and Leading Players Analysis Through 2029
What Is the Current Market Size and Growth Rate of the Automated And Closed Cell Therapy Processing Systems Market?
The automated and closed cell therapy processing systems market size has grown rapidly in recent years. It will grow from $1.31 billion in 2024 to $1.53 billion in 2025 at a compound annual growth rate (CAGR) of 17.2%. The growth in the historic period can be attributed to increasing demand for personalized medicine, growing cell and gene therapy pipeline, rising clinical trials for cell-based therapies, expansion of biopharmaceutical manufacturing capabilities, and increasing investment in regenerative medicine.
The automated and closed cell therapy processing systems market size is expected to see rapid growth in the next few years. It will grow to $2.86 billion in 2029 at a compound annual growth rate (CAGR) of 16.9%. The growth in the forecast period can be attributed to growing adoption of automation in cell therapy manufacturing, rising regulatory support for advanced therapy medicinal products, increasing need for scalable and reproducible processes, expanding applications of cell therapies beyond oncology, and rising demand for cost-effective manufacturing solutions. Major trends in the forecast period include technology advancements in automated cell processing platforms, innovations in closed-system bioreactors, developments in artificial intelligence integration, research and development in modular manufacturing systems, and increasing focus on end-to-end process automation.
Claim your free report sample now:
Which Factors Are Driving Growth in the Automated And Closed Cell Therapy Processing Systems Market?
The growing demand for personalized medicine is expected to propel the growth of the automated and closed cell therapy processing systems market going forward. Personalized medicine is a medical approach that tailors treatment and healthcare decisions to an individual’s unique genetic, molecular, and clinical profile. The growing demand for personalized medicine is due to patients seeking tailored treatments that improve effectiveness, reduce side effects, and align with their unique biological makeup. Automated and closed-cell therapy processing systems support personalized medicine by enabling precise, sterile, and consistent manufacturing of patient-specific therapies with minimal contamination and manual intervention. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and health care organization, in 2023, the Food and Drug Administration (FDA), a US-based federal agency, approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the growing demand for personalized medicine is driving the growth of the automated and closed-cell therapy processing systems market.
What Are the Core Segments Shaping the Automated And Closed Cell Therapy Processing Systems Market Landscape?
The automated and closed cell therapy processing systems market covered in this report is segmented
1) By Component: Software, Hardware, Consumables
2) By Technology: Microfluidics, Robotics, Bioreactors, Single-Use Technology, Three-Dimensional (3D) Cell Culture
3) By Workflow: Cryopreservation, Separation, Fill-Finish, Expansion, Apheresis, Other Workflows
4) By Application: Oncology, Regenerative Medicine, Autoimmune Diseases, Infectious Diseases, Cardiovascular Diseases
5) By End User: Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Contract Manufacturing Organizations, Hospitals
Subsegment:
1) By Software: Process Control Software, Data Management Software, Quality Monitoring Software, Workflow Automation Software, Integration Software
2) By Hardware: Cell Separation Devices, Bioreactors, Fluid Handling Systems, Centrifuges, Tubing And Connectors
3) By Consumables: Sterile Bags, Culture Media, Reagents And Buffers, Filters And Cartridges, Single-Use Tubing Sets
What Are the Top Trends Expected to Shape the Automated And Closed Cell Therapy Processing Systems Market by 2029?
Major companies operating in the automated and closed cell therapy processing systems market are focusing on developing advanced solutions, such as cell preparation platforms, to reduce manual labor and the risk of contamination during cell processing. Cell preparation platforms are automated systems used to isolate, process, and prepare cells efficiently for further analysis or clinical use. For instance, in October 2024, Sino-Biocan Biotechnology Ltd., a China-based biotech company, launched the WUKONG Automated, Closed, Integrated Cell Processing System, which marks a major advancement in cell therapy manufacturing, providing a fully automated, closed platform that streamlines processes from blood collection to cell culture and final filling. It is designed to serve hospitals, pharmaceutical research and development teams, and contract development and manufacturing organizations by improving efficiency, reducing contamination risks, and ensuring good manufacturing practice-grade consistency through intelligent controls and real-time monitoring.
Which Are the Top Companies in the Automated And Closed Cell Therapy Processing Systems Market?
Major companies operating in the automated and closed cell therapy processing systems market are Thermo Fisher Scientific Inc., Fresenius SE & Co. KGaA, Danaher Corporation, Merck KGaA, Parker Hannifin Corp., Corning Incorporated, Kawasaki Heavy Industries Ltd., Dover Corporation, Lonza Group AG, Terumo Corporation, Sartorius AG, Charles River Laboratories International Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Hamilton Company, Repligen Corporation, Cellares Inc., Ori Biotech Ltd., and Autolus Therapeutics Plc.
Get the full automated and closed cell therapy processing systems market report here:
Which Regions Are Driving the Most Demand in the Automated And Closed Cell Therapy Processing Systems Market?
North America was the largest region in the automated and closed cell therapy processing systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated and closed cell therapy processing systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
Comments
Post a Comment